Imitation to Innovation in China
The Role of Patents in Biotechnology and Pharmaceutical Industries
Published on 30. July 2010
Book
Hardback
208 pages
978-1-84844-206-1 (ISBN)
Description
Following decades in which China's approach to technology has been to imitate, the country is now transforming itself to become innovation-oriented. This pioneering study examines whether patents play a similar role in promoting innovation in China as they do in the West, exploring the interplay between patents and China's biotechnology and pharmaceutical industries in particular.
The author argues for a stronger patent regime based on an extensive review of the technological capacity, R&D models, patent filings and litigations, and issues in patent law, which involve China's biotechnology and pharmaceutical industries. By comparing China with other developing countries and analyzing China's uniqueness in terms of its development stage, technological capacity and the strengths and weaknesses in its patent system, Yahong Li concludes that China is distinguished from the prevailing view that patents play a limited role in innovation in developing countries. The book also discusses whether and how patents can promote innovation in China's biotechnology and pharmaceutical industries, based on the study of market scale, R&D capacity, innovation model and patent legislation and cases.
This comprehensively researched book will be invaluable to multinational biotechnology and pharmaceutical companies either doing business or planning to do business in China. Practitioners and policymakers as well as academics and students specializing in IP law, economics and technology should also not be without this eloquent book.
The author argues for a stronger patent regime based on an extensive review of the technological capacity, R&D models, patent filings and litigations, and issues in patent law, which involve China's biotechnology and pharmaceutical industries. By comparing China with other developing countries and analyzing China's uniqueness in terms of its development stage, technological capacity and the strengths and weaknesses in its patent system, Yahong Li concludes that China is distinguished from the prevailing view that patents play a limited role in innovation in developing countries. The book also discusses whether and how patents can promote innovation in China's biotechnology and pharmaceutical industries, based on the study of market scale, R&D capacity, innovation model and patent legislation and cases.
This comprehensively researched book will be invaluable to multinational biotechnology and pharmaceutical companies either doing business or planning to do business in China. Practitioners and policymakers as well as academics and students specializing in IP law, economics and technology should also not be without this eloquent book.
Reviews / Votes
'This volume fills an important need for understanding about the interplay between China's intellectual property protection system and the potential for innovation in China's economy. Using examples from the pharmaceutical and biotech industries, the author suggests that, despite the widely documented challenges facing China's IPR protection system, the system has a demonstrable effect on innovation. The author suggests that China's patent system promotes innovation through economic incentives, soft factors of public encouragement, and intentional development strategies. This book is also useful as an overview of China's biotech and pharmaceutical sectors, offering a range of richly detailed case studies on China's industrial development strategies in these sectors. A number of important patent disputes between Chinese and foreign companies are also examined to useful effect. In the highly contentious policy world of intellectual property protection and pharmaceutical and biotech industry development, the volume offers a refreshing combination of detail and insight.' -- Pitman B. Potter, University of British Columbia, Canada 'Yahong Li's pioneering study, Imitation to Innovation in China, breaks new ground in closely examining the extent to which the Chinese government's patent policies and patent activity by Chinese firms are influencing China's coming transformation from an imitation-oriented country to an innovation-oriented one. Her combination of theoretical and empirical approaches exploring the links between public policy, patenting activity and technological innovation (commercialization) is an important contribution to development studies, not just for China but for other newly innovative countries as well.' -- William O. Hennessey, Franklin Pierce Law Center, USMore details
Series
Language
English
Place of publication
Cheltenham
United Kingdom
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 234 mm
Width: 156 mm
ISBN-13
978-1-84844-206-1 (9781848442061)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Person
Yahong Li, Associate Professor and Director, LLM Program in Intellectual Property and Information Technology, Faculty of Law, University of Hong Kong
Content
Contents: Foreword Preface 1. The Role of Patents in Innovation: Introduction 2. An Overview of China's Biotechnology and Pharmaceutical Industries 3. Innovation Capacity and Infrastructure 4. Models of R&D and Commercialization 5. The Role of Patents in Innovation: Case Studies 6. Patentable Biotechnology and Pharmaceutical Inventions 7. Patentability of Biotechnology and Pharmaceutical Inventions 8. Patent Rights in Biotechnology and Pharmaceutical Inventions 9. The Role of Patents in Innovation: Further Reflections Index